Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal Article (Journal Article)
Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as retroperitoneal/intra-abdominal STS, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recommendations, and reviews the evidence to support the guidelines recommendations.
Full Text
Duke Authors
Cited Authors
- von Mehren, M; Kane, JM; Agulnik, M; Bui, MM; Carr-Ascher, J; Choy, E; Connelly, M; Dry, S; Ganjoo, KN; Gonzalez, RJ; Holder, A; Homsi, J; Keedy, V; Kelly, CM; Kim, E; Liebner, D; McCarter, M; McGarry, SV; Mesko, NW; Meyer, C; Pappo, AS; Parkes, AM; Petersen, IA; Pollack, SM; Poppe, M; Riedel, RF; Schuetze, S; Shabason, J; Sicklick, JK; Spraker, MB; Zimel, M; Hang, LE; Sundar, H; Bergman, MA
Published Date
- July 2022
Published In
Volume / Issue
- 20 / 7
Start / End Page
- 815 - 833
PubMed ID
- 35830886
Electronic International Standard Serial Number (EISSN)
- 1540-1413
Digital Object Identifier (DOI)
- 10.6004/jnccn.2022.0035
Language
- eng
Conference Location
- United States